Brief: YiChang HEC ChangJiang Pharmaceutical Says Amlodipine Besylate Tablets Passed Consistency Evaluation
04/11/2019 13:35
Nov 4 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* ANNOUNCES PASSING OF CONSISTENCY EVALUATION FOR AMLODIPINE
BESYLATE TABLETS
Source text for Eikon: urn:newsml:reuters.com:*:nHKS5CKkz
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million